Genomic rearrangements involving programmed death ligands are recurrent in primary mediastinal large B-cell lymphoma

The pathogenesis of primary mediastinal large B-cell lymphoma (PMBCL) is incompletely understood. Recently, specific genotypic and phenotypic features have been linked to tumor cell immune escape mechanisms in PMBCL. We studied 571 B-cell lymphomas with a focus on PMBCL. Using fluorescence in situ h...

Full description

Saved in:
Bibliographic Details
Published inBlood Vol. 123; no. 13; pp. 2062 - 2065
Main Authors Twa, David D.W., Chan, Fong Chun, Ben-Neriah, Susana, Woolcock, Bruce W., Mottok, Anja, Tan, King L., Slack, Graham W., Gunawardana, Jay, Lim, Raymond S., McPherson, Andrew W., Kridel, Robert, Telenius, Adele, Scott, David W., Savage, Kerry J., Shah, Sohrab P., Gascoyne, Randy D., Steidl, Christian
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 27.03.2014
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The pathogenesis of primary mediastinal large B-cell lymphoma (PMBCL) is incompletely understood. Recently, specific genotypic and phenotypic features have been linked to tumor cell immune escape mechanisms in PMBCL. We studied 571 B-cell lymphomas with a focus on PMBCL. Using fluorescence in situ hybridization here, we report that the programmed death ligand (PDL) locus (9p24.1) is frequently and specifically rearranged in PMBCL (20%) as compared with diffuse large B-cell lymphoma, follicular lymphoma, and Hodgkin lymphoma. Rearrangement was significantly correlated with overexpression of PDL transcripts. Utilizing high-throughput sequencing techniques, we characterized novel translocations and chimeric fusion transcripts involving PDLs at base-pair resolution. Our data suggest that recurrent genomic rearrangement events underlie an immune privilege phenotype in a subset of B-cell lymphomas. •Programmed death ligands 1 and 2 are rearranged at a frequency of 20% in PMBCL.
ISSN:0006-4971
1528-0020
DOI:10.1182/blood-2013-10-535443